ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
67.968,03
0,36%
Brent Oil
81,295
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Canadá
  5. TSXV
  6. Cotinga Pharmaceuticals Inc (COT)

  7. Cotinga Pharmaceuticals Inc (COT) Notícias

COT

Cotinga Pharmaceuticals (COT)

Cotinga Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:TSXV:COT
DataHoraFonteTítuloCódigoCompanhia
15/10/202009:01PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - COTTSXV:COTCotinga Pharmaceuticals Inc
15/10/202008:55PR Newswire (Canada)IIROC Trading Halt - COTTSXV:COTCotinga Pharmaceuticals Inc
07/11/201918:10PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - COTTSXV:COTCotinga Pharmaceuticals Inc
07/11/201918:09PR Newswire (Canada)IIROC Trading Resumption - COTTSXV:COTCotinga Pharmaceuticals Inc
24/07/201417:20Marketwired CanadaCritical Outcome Technologies Reports Year-End Financial and Operating ResultsTSXV:COTCotinga Pharmaceuticals Inc
23/06/201410:00MarketwiredCritical Outcome Technologies Seeks to Redefine Personalized Cancer Care With Project ROSALINDTSXV:COTCotinga Pharmaceuticals Inc
17/06/201410:00MarketwiredCritical Outcome Technologies Receives Orphan Drug Designation For COTI-2TSXV:COTCotinga Pharmaceuticals Inc
16/06/201410:00Marketwired CanadaCritical Outcome Technologies to Commence Trading in U.S. on OTCQB Under Symbol COTQFTSXV:COTCotinga Pharmaceuticals Inc
13/06/201420:42Marketwired CanadaCritical Outcome Technologies Inc.: SeeThruEquity Initiates Research CoverageTSXV:COTCotinga Pharmaceuticals Inc
13/06/201410:00MarketwiredCritical Outcome Technologies Invited to Present at 16th International p53 Workshop in SwedenTSXV:COTCotinga Pharmaceuticals Inc
04/06/201410:00MarketwiredCritical Outcome Technologies Inc. Completes FinancingTSXV:COTCotinga Pharmaceuticals Inc
27/05/201417:48Marketwired CanadaCritical Outcome Technologies Inc. Announces Warrant Term AmendmentTSXV:COTCotinga Pharmaceuticals Inc
27/05/201410:00MarketwiredCritical Outcome Technologies Selected to Present at Multiple Investor Conferences in New York CityTSXV:COTCotinga Pharmaceuticals Inc
22/05/201410:00Access WireSeeThruEquity 3rd Annual Microcap Investor Conference To Be Held May 28, 2014TSXV:COTCotinga Pharmaceuticals Inc
01/05/201409:48MarketwiredFinancing Increases Runway to the Clinic for COTI-2, Critical Outcome's Lead Cancer Drug CandidateTSXV:COTCotinga Pharmaceuticals Inc
14/04/201417:30Marketwired CanadaCritical Outcome Technologies Announces Warrant IssuanceTSXV:COTCotinga Pharmaceuticals Inc
04/04/201410:00MarketwiredCritical Outcome Technologies Applies for Orphan Drug Designation for COTI-2 Treatment of Ovarian CancerTSXV:COTCotinga Pharmaceuticals Inc
14/03/201410:00MarketwiredCritical Outcome Technologies Reports Third Quarter ResultsTSXV:COTCotinga Pharmaceuticals Inc
26/02/201411:29MarketwiredCritical Outcome Technologies Identifies Experienced Partner for Clinical Development of COTI-2TSXV:COTCotinga Pharmaceuticals Inc
06/02/201412:13MarketwiredCritical Outcome Technologies Completes Private PlacementTSXV:COTCotinga Pharmaceuticals Inc
05/02/201411:00Marketwired CanadaCritical Outcome Technologies Announces Engagement of Maxim Group LLCTSXV:COTCotinga Pharmaceuticals Inc
18/12/201319:48MarketwiredCritical Outcome Technologies Reports Second Quarter ResultsTSXV:COTCotinga Pharmaceuticals Inc
06/12/201319:05MarketwiredCritical Outcome Technologies Awards Stock OptionsTSXV:COTCotinga Pharmaceuticals Inc
06/12/201311:47MarketwiredCritical Outcome Technologies Provides Business and Scientific Update at Annual General MeetingTSXV:COTCotinga Pharmaceuticals Inc
13/11/201311:00Marketwired CanadaCOTI-2, a P53 Dependent Treatment for Many Common Cancers, Receives Additional U.S. Patent ProtectionTSXV:COTCotinga Pharmaceuticals Inc
29/10/201318:15Marketwired CanadaCritical Outcome Technologies Announces Warrant Expiry Date AmendmentTSXV:COTCotinga Pharmaceuticals Inc
15/10/201317:30Marketwired CanadaCritical Outcome Technologies Grants Stock OptionsTSXV:COTCotinga Pharmaceuticals Inc
03/10/201310:45Marketwired CanadaCritical Outcome Technologies to Present at the 12th Annual BIO Investor ForumTSXV:COTCotinga Pharmaceuticals Inc
27/09/201317:05Marketwired CanadaCritical Outcome Technologies Reports Fiscal 2014 First Quarter ResultsTSXV:COTCotinga Pharmaceuticals Inc
11/09/201317:05Marketwired CanadaCritical Outcome Technologies Announces Warrant Term AmendmentsTSXV:COTCotinga Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:TSXV:COT

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
RNEW4
RENOVA PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados